Biogen Total Assets 2006-2019 | BIIB

Biogen total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Biogen total assets for the quarter ending March 31, 2019 were $26.446B, a 1.36% increase year-over-year.
  • Biogen total assets for 2018 were $25.289B, a 6.92% increase from 2017.
  • Biogen total assets for 2017 were $23.653B, a 3.39% increase from 2016.
  • Biogen total assets for 2016 were $22.877B, a 17.29% increase from 2015.
Biogen Annual Total Assets
(Millions of US $)
2018 $25,289
2017 $23,653
2016 $22,877
2015 $19,505
2014 $14,315
2013 $11,863
2012 $10,130
2011 $9,050
2010 $8,092
2009 $8,552
2008 $8,479
2007 $8,629
2006 $8,553
2005 $8,382
Biogen Quarterly Total Assets
(Millions of US $)
Q1 2019 $26,446
Q4 2018 $25,289
Q3 2018 $25,492
Q2 2018 $23,953
Q1 2018 $26,090
Q4 2017 $23,653
Q3 2017 $23,073
Q2 2017 $21,759
Q1 2017 $21,196
Q4 2016 $22,877
Q3 2016 $22,105
Q2 2016 $21,515
Q1 2016 $20,675
Q4 2015 $19,505
Q3 2015 $20,728
Q2 2015 $16,759
Q1 2015 $15,219
Q4 2014 $14,315
Q3 2014 $13,704
Q2 2014 $12,918
Q1 2014 $12,230
Q4 2013 $11,863
Q3 2013 $11,250
Q2 2013 $10,842
Q1 2013 $10,165
Q4 2012 $10,130
Q3 2012 $9,631
Q2 2012 $9,162
Q1 2012 $9,114
Q4 2011 $9,050
Q3 2011 $8,802
Q2 2011 $8,622
Q1 2011 $8,294
Q4 2010 $8,092
Q3 2010 $7,394
Q2 2010 $7,502
Q1 2010 $8,217
Q4 2009 $8,552
Q3 2009 $9,026
Q2 2009 $8,777
Q1 2009 $8,575
Q4 2008 $8,479
Q3 2008 $8,535
Q2 2008 $8,173
Q1 2008 $8,171
Q4 2007 $8,629
Q3 2007 $7,816
Q2 2007 $8,936
Q1 2007 $8,710
Q4 2006 $8,553
Q3 2006 $8,187
Q2 2006 $8,340
Q1 2006 $8,524
Q4 2005 $8,382
Q3 2005 $8,315
Q2 2005 $8,268
Q1 2005 $9,063
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $45.741B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.734B 12.75
Gilead Sciences (GILD) United States $87.764B 10.66
Celgene (CELG) United States $65.921B 11.17
Illumina (ILMN) United States $52.588B 60.94
Vertex Pharmaceuticals (VRTX) United States $46.363B 56.04
Regeneron Pharmaceuticals (REGN) United States $34.154B 16.05
Alexion Pharmaceuticals (ALXN) United States $28.474B 16.11
Incyte (INCY) United States $18.639B 75.58
BioMarin Pharmaceutical (BMRN) United States $15.382B 0.00
Exact Sciences (EXAS) United States $14.692B 0.00
Seattle Genetics (SGEN) United States $11.395B 0.00
Array BioPharma (ARRY) United States $10.252B 0.00
Sarepta Therapeutics (SRPT) United States $9.443B 0.00
QIAGEN (QGEN) Netherlands $9.174B 30.13
Bio-Techne Corp (TECH) United States $7.796B 53.19
Guardant Health (GH) United States $7.678B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.649B 0.00
Galapagos (GLPG) Belgium $6.527B 0.00
Bluebird Bio (BLUE) United States $6.504B 0.00
Exelixis (EXEL) United States $6.259B 15.95
Amarin (AMRN) Ireland $6.091B 0.00
BeiGene (BGNE) Cayman Islands $5.612B 0.00
Ascendis Pharma (ASND) Denmark $5.108B 0.00
Moderna (MRNA) United States $4.619B 0.00
Blueprint Medicines (BPMC) United States $4.535B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.494B 0.00
Spark Therapeutics (ONCE) United States $3.915B 0.00
Repligen (RGEN) United States $3.868B 96.36
China Biologic Products (CBPO) China $3.718B 23.62
ACADIA Pharmaceuticals (ACAD) United States $3.718B 0.00
Mirati Therapeutics (MRTX) United States $3.632B 0.00
Global Blood Therapeutics (GBT) United States $3.570B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.462B 0.00
Alkermes (ALKS) Ireland $3.391B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.305B 0.00
Allogene Therapeutics (ALLO) United States $3.226B 0.00
UniQure (QURE) Netherlands $2.820B 0.00
Arena Pharmaceuticals (ARNA) United States $2.796B 5.68
Amicus Therapeutics (FOLD) United States $2.763B 0.00
Lion Biotechnologies (IOVA) United States $2.635B 0.00
Medicines (MDCO) United States $2.613B 0.00
Reata Pharmaceuticals (RETA) United States $2.580B 0.00
Immunomedics (IMMU) United States $2.452B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.374B 0.00
Emergent Biosolutions (EBS) United States $2.350B 20.41
Halozyme Therapeutics (HALO) United States $2.344B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.294B 0.00
NeoGenomics (NEO) United States $2.205B 144.38
Ligand Pharmaceuticals (LGND) United States $2.161B 17.90
MyoKardia (MYOK) United States $2.141B 0.00
Akcea Therapeutics (AKCA) United States $2.140B 0.00
Acceleron Pharma (XLRN) United States $2.115B 0.00
Insmed (INSM) United States $2.023B 0.00
Genomic Health (GHDX) United States $1.984B 42.13
Zai Lab Unsponsored ADR (ZLAB) China $1.979B 0.00
Denali Therapeutics (DNLI) United States $1.874B 0.00
REGENXBIO (RGNX) United States $1.837B 0.00
Allakos (ALLK) United States $1.774B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.772B 0.00
Myriad Genetics (MYGN) United States $1.691B 16.82
Audentes Therapeutics (BOLD) United States $1.656B 0.00
Cambrex (CBM) United States $1.488B 18.81
Coherus BioSciences (CHRS) United States $1.480B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.464B 0.00
Gossamer Bio (GOSS) United States $1.460B 0.00
Apellis Pharmaceuticals (APLS) United States $1.458B 0.00
AnaptysBio (ANAB) United States $1.454B 0.00
Innoviva (INVA) United States $1.438B 3.98
Epizyme (EPZM) United States $1.373B 0.00
Alector (ALEC) United States $1.256B 0.00
Fate Therapeutics (FATE) United States $1.241B 0.00
Aimmune Therapeutics (AIMT) United States $1.223B 0.00
Athenex (ATNX) United States $1.203B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.169B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.146B 0.00
RA PHARMCTL INC (RARX) United States $1.109B 0.00
Sangamo Therapeutics (SGMO) United States $1.104B 0.00
Rubius Therapeutics (RUBY) United States $1.096B 0.00
Editas Medicine (EDIT) United States $1.073B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.051B 0.00
Codexis (CDXS) United States $1.022B 0.00
G1 THERAPEUTICS (GTHX) United States $1.018B 0.00
Eidos Therapeutics (EIDX) United States $1.003B 0.00
Twist Bioscience (TWST) United States $0.956B 0.00
CORTEXYME INC (CRTX) United States $0.953B 0.00
Atara Biotherapeutics (ATRA) United States $0.946B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.935B 0.00
ANI Pharmaceuticals (ANIP) United States $0.926B 16.43
NGM Biopharmaceuticals (NGM) United States $0.914B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.911B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.879B 0.00
WAVE Life Sciences (WVE) Singapore $0.873B 0.00
Principia Biopharma (PRNB) United States $0.847B 0.00
Retrophin (RTRX) United States $0.842B 0.00
Axsome Therapeutics (AXSM) United States $0.782B 0.00
Cara Therapeutics (CARA) United States $0.778B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.775B 0.00
Vericel (VCEL) United States $0.766B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.765B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.752B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.740B 0.00
Kura Oncology (KURA) United States $0.732B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.732B 34.55
Rhythm Pharmaceuticals (RYTM) United States $0.727B 0.00
MeiraGTx Holdings (MGTX) United States $0.716B 0.00
Clovis Oncology (CLVS) United States $0.707B 0.00
Arvinas (ARVN) United States $0.707B 0.00
Zymeworks (ZYME) Canada $0.705B 0.00
Adverum Biotechnologies (ADVM) United States $0.699B 0.00
Intra-Cellular Therapies (ITCI) United States $0.696B 0.00
Myovant Sciences (MYOV) United Kingdom $0.672B 0.00
Precision BioSciences (DTIL) United States $0.665B 0.00
Zealand Pharma (ZEAL) Denmark $0.654B 7.64
Heska (HSKA) United States $0.652B 66.71
Intellia Therapeutics (NTLA) United States $0.650B 0.00
Stemline Therapeutics (STML) United States $0.644B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.640B 0.00
Cytokineticsorporated (CYTK) United States $0.625B 0.00
Cellectis (CLLS) France $0.621B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.612B 0.00
Krystal Biotech (KRYS) United States $0.595B 0.00
Viking Therapeutics (VKTX) United States $0.573B 0.00
Anika Therapeutics (ANIK) United States $0.552B 18.85
Milestone Pharmaceuticals (MIST) Canada $0.543B 0.00
ObsEva SA (OBSV) Switzerland $0.520B 0.00
Puma Biotechnology (PBYI) United States $0.510B 0.00
Revance Therapeutics (RVNC) United States $0.508B 0.00
Magenta Therapeutics (MGTA) United States $0.504B 0.00
DBV Technologies (DBVT) France $0.502B 0.00
Mesoblast (MESO) Australia $0.471B 0.00
BeyondSpring (BYSI) United States $0.469B 0.00
Provention Bio (PRVB) United States $0.469B 0.00
CytomX Therapeutics (CTMX) United States $0.468B 0.00
UROGEN PHARMA (URGN) United States $0.451B 0.00
Sorrento Therapeutics (SRNE) United States $0.450B 0.00
Kodiak Sciences (KOD) United States $0.424B 0.00
Arcus Biosciences (RCUS) United States $0.413B 0.00
MediciNova (MNOV) United States $0.406B 0.00
Replimune (REPL) United States $0.405B 0.00
Agenus (AGEN) United States $0.404B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.397B 0.00
Synthorx (THOR) United States $0.393B 0.00
Scholar Rock Holding (SRRK) United States $0.391B 0.00
BioDelivery Sciences (BDSI) United States $0.390B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.386B 0.00
Prothena (PRTA) Ireland $0.382B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.379B 0.00
UNITY Biotechnology (UBX) $0.378B 0.00
Albireo Pharma (ALBO) United States $0.378B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Kaleido Biosciences (KLDO) $0.368B 0.00
ResTORbio (TORC) United States $0.361B 0.00
AVROBIO (AVRO) United States $0.358B 0.00
PDL BioPharma (PDLI) United States $0.358B 8.54
Acorda Therapeutics (ACOR) United States $0.356B 6.27
AC Immune SA (ACIU) Switzerland $0.355B 22.83
Gritstone Oncology (GRTS) United States $0.348B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.346B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.343B 0.00
Senesco Technologies (ELOX) United States $0.321B 0.00
Merus (MRUS) Netherlands $0.321B 0.00
NEXTCURE INC (NXTC) United States $0.319B 0.00
Kindred Biosciences (KIN) United States $0.316B 0.00
Cyclerion Therapeutics (CYCN) United States $0.295B 0.00
LogicBio Therapeutics (LOGC) United States $0.294B 0.00
Cel-Sci (CVM) United States $0.292B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.289B 0.00
PHASEBIO PHARMA (PHAS) United States $0.286B 0.00
Geron (GERN) United States $0.284B 0.00
Evelo Biosciences (EVLO) United States $0.277B 0.00
Protagonist Therapeutics (PTGX) United States $0.277B 0.00
Syros Pharmaceuticals (SYRS) United States $0.274B 0.00
Cellular Biomedicine (CBMG) United States $0.271B 0.00
Sutro Biopharma (STRO) United States $0.268B 0.00
XBiotech (XBIT) United States $0.265B 0.00
Athersys (ATHX) United States $0.262B 0.00
Palatin Technologies (PTN) United States $0.261B 0.00
Dynavax Technologies (DVAX) United States $0.247B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.246B 0.00
Chiasma (CHMA) United States $0.245B 0.00
Urovant Sciences (UROV) United States $0.242B 0.00
Constellation Pharmaceuticals (CNST) United States $0.239B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Neothetics (EVFM) United States $0.236B 0.00
Synlogic (SYBX) United States $0.236B 0.00
Spero Therapeutics (SPRO) United States $0.236B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.232B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.230B 0.00
AXCELLA HEALTH (AXLA) United States $0.228B 0.00
Five Prime Therapeutics (FPRX) United States $0.221B 0.00
Kadmon Holdings (KDMN) United States $0.220B 0.00
Kamada (KMDA) Israel $0.219B 8.52
Abeona Therapeutics (ABEO) United States $0.218B 0.00
Avid Bioservices (CDMO) United States $0.215B 0.00
ADMA Biologics Inc (ADMA) United States $0.213B 0.00
Cerecor (CERC) United States $0.210B 0.00
Celcuity (CELC) United States $0.208B 0.00
MannKind (MNKD) United States $0.207B 0.00
ChromaDex (CDXC) United States $0.206B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.204B 0.00
Pfenex (PFNX) United States $0.203B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.201B 0.00
Enochian BioSciences (ENOB) United States $0.197B 0.00
IDEAYA BIOSCI (IDYA) United States $0.194B 0.00
Compugen (CGEN) Israel $0.194B 0.00
Mersana Therapeutics (MRSN) United States $0.193B 0.00
Kala Pharmaceuticals (KALA) United States $0.189B 0.00
Arsanis (XFOR) United States $0.185B 0.00
CorMedix Inc (CRMD) United States $0.185B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.183B 0.00
Affimed (AFMD) Germany $0.182B 0.00
Enzo Biochem (ENZ) United States $0.180B 0.00
Solid Biosciences (SLDB) United States $0.175B 0.00
Strongbridge Biopharma (SBBP) United States $0.175B 10.09
Gamida Cell (GMDA) Israel $0.174B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
OSMOTICA PHARM (OSMT) United States $0.171B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Cue Biopharma (CUE) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.163B 0.00
Anavex Life Sciences (AVXL) United States $0.163B 0.00
OvaScience (MLND) United States $0.161B 0.00
Liquidia Technologies (LQDA) United States $0.156B 0.00
BioTime (BTX) United States $0.153B 10.20
APPLIED THERAPT (APLT) United States $0.148B 0.00
Aduro Biotech (ADRO) United States $0.148B 0.00
TREVI THERAPTCS (TRVI) United States $0.147B 0.00
Kezar Life Sciences (KZR) United States $0.146B 0.00
Axovant Sciences (AXGT) United States $0.146B 0.00
Menlo Therapeutics (MNLO) United States $0.146B 0.00
Mustang Bio (MBIO) United States $0.143B 0.00
HOOKIPA PHARMA (HOOK) United States $0.141B 0.00
TOCAGEN INC (TOCA) United States $0.139B 0.00
XOMA (XOMA) United States $0.137B 0.00
Intec Pharma (NTEC) Israel $0.137B 0.00
Checkpoint Therapeutics (CKPT) United States $0.134B 0.00
Verastem (VSTM) United States $0.130B 0.00
Alcobra (ARCT) United States $0.128B 0.00
Novavax (NVAX) United States $0.127B 0.00
VBI Vaccines (VBIV) United States $0.126B 0.00
Eton Pharmaceuticals (ETON) United States $0.125B 0.00
Arbutus Biopharma (ABUS) Canada $0.124B 0.00
Seres Therapeutics (MCRB) United States $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Celyad SA (CYAD) Belgium $0.122B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.119B 0.00
VolitionRX (VNRX) Singapore $0.119B 0.00
Aptose Biosciences (APTO) Canada $0.119B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.114B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.112B 0.00
Aptinyx (APTX) United States $0.112B 0.00
Fortress Biotech (FBIO) United States $0.107B 0.00
NantKwest (NK) United States $0.105B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.100B 0.00
Equillium (EQ) United States $0.098B 0.00
INmune Bio (INMB) United States $0.094B 0.00
Allena Pharmaceuticals (ALNA) United States $0.094B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.090B 0.00
Catalyst Biosciences (CBIO) United States $0.090B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.089B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.087B 0.00
Trevena (TRVN) United States $0.087B 0.00
Pluristem Therapeutics (PSTI) Israel $0.084B 0.00
Selecta Biosciences (SELB) United States $0.084B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Idera Pharmaceuticals (IDRA) United States $0.076B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.074B 0.00
Unum Therapeutics (UMRX) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.073B 0.00
Cohbar (CWBR) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
AquaBounty Technologies (AQB) United States $0.068B 0.00
OVID THERAPEUTC (OVID) United States $0.068B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.067B 0.00
VTv Therapeutics (VTVT) United States $0.066B 0.00
Cocrystal Pharma (COCP) United States $0.066B 69.67
Protalix BioTherapeutics (PLX) Israel $0.066B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Zosano Pharma (ZSAN) United States $0.056B 0.00
Ophthotech (ISEE) United States $0.056B 0.00
DiaMedica Therapeutics (DMAC) United States $0.055B 0.00
Moleculin Biotech (MBRX) United States $0.055B 0.00
ScPharmaceuticals (SCPH) United States $0.054B 0.00
Curis (CRIS) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Organovo Holdings (ONVO) United States $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Eyenovia (EYEN) United States $0.052B 0.00
Hoth Therapeutics (HOTH) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
Cidara Therapeutics (CDTX) United States $0.045B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Aptevo Therapeutics (APVO) United States $0.042B 0.00
Entera Bio (ENTX) Israel $0.041B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Leap Therapeutics (LPTX) United States $0.038B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
VIVUS (VVUS) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Aytu Bioscience (AYTU) United States $0.030B 0.00
Edge Therapeutics (PDSB) United States $0.029B 0.00
Bison Capital Acquisition (XYN) China $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Sophiris Bio (SPHS) United States $0.025B 0.00
Oragenics (OGEN) United States $0.022B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.021B 0.00
TRACON Pharmaceuticals (TCON) United States $0.021B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
Vical (VICL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Vital Therapies (IMUX) United States $0.019B 0.00
Histogenics (HSGX) United States $0.018B 0.00
ATyr Pharma (LIFE) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
OncoSec Medical (ONCS) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Aileron Therapeutics (ALRN) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Motif Bio Plc (MTFB) United States $0.011B 0.00
IMMURON LTD (IMRN) Australia $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
AmpliPhi Biosciences (ARMP) United States $0.008B 0.00
Therapix Biosciences (TRPX) Israel $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Neuralstem (CUR) United States $0.006B 0.00
Stellar Biotechnologies (EDSA) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Galena Biopharma (SLS) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00
MEREO BIOPHARMA (MREO) $0.000B 0.00